HannahRoseSnyderMD

Physician

Dr. Snyder is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
995 Potrero Ave
Bldg 80, Wd 83
San Francisco, CA 94110
Phone+1 415-206-8611

Fax+1 415-206-8387

University of California (San Francisco)Residency, Family Medicine, 2014 - 2017
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2014

PubMed

Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease.
Derek D Satre, Dhweeja Dasarathy, Steven L Batki, Michael J Ostacher, Hannah R Snyder
Alimentary Pharmacology & Therapeutics. 2025-02-01
Demographic and clinical characteristics associated with utilization of alcohol use disorder treatment in a multicenter study of patients with alcohol-associated cirrh...
Jeremy W Luk, Nghiem B Ha, Amy M Shui, Hannah R Snyder, Steven L Batki
Alcohol, Clinical & Experimental Research. 2025-01-01
3 citations
Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study.
Benjamin L H Jones, Michelle Geier, John Neuhaus, Phillip O Coffin, Hannah R Snyder
Harm Reduction Journal. 2024-04-09

SF Clinic Eagerly Awaits Expanded Methadone AccessSeptember 27th, 2024
Buprenorphine Proves Effective for Fentanyl Users in the EDMarch 9th, 2023
Can a Monthly Injection Be the Key to Curbing Addiction? These Experts Say YesMay 6th, 2022
Join now to see all

Leveraging Latent Factors and Machine Learning to Forecast Internalizing Psychopathology in Emerging AdulthoodUNIVERSITY OF COLORADO2022–2027